A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this research study is to evaluate the safety and effectiveness of a new oral antibiotic called SMT19969 in treating C. difficile Infection (CDI).
Epistemonikos ID: 5ed125f2ca22d8a5e4072055041be6d76d57a22b
First added on: May 11, 2024